new

Get trending papers in your email inbox!

Subscribe

Daily Papers

byAK and the research community

Nov 20

The Effect of Quantization on Clinical Benchmarks: Accuracy and Safety Across Model Families

Quantization enables deployment of large language models on resource-constrained clinical edge devices, but its effect on clinical accuracy and safety remains understudied. We evaluate five 7-8B parameter models at FP16, GPTQ-INT8, and GPTQ-INT4 precision across five benchmarks: MedQA, MedMCQA, Med-HALT, a risk-stratified sample of HealthBench, and MedSafetyBench. The study jointly varies quantization bit width, model family, and clinical task type, with explicit risk stratification and safety measures. INT8 GPTQ is universally safe (max. degradation -1.9%-1.9%), while INT4 degradation is substantial and model-dependent: BioMistral-7B, clinically fine-tuned, loses 19.7% on MedMCQA, more than any general-purpose model, showing clinical fine-tuning does not confer compression robustness. MedMCQA degrades more than MedQA under INT4; Med-HALT is largely unaffected. On HealthBench's emergency-risk subgroup, Qwen2.5-7B degrades by 26.8% under INT4, suggesting high-risk scenarios are disproportionately vulnerable to compression. On MedSafetyBench, the model family dominates over precision (refusal rates range 10.2%-74.9% at FP16), though Qwen2.5-7B (-17.8%) and Meditron-7B (-28.3%) show substantial INT4 safety degradation; notably, Qwen2.5-7B is simultaneously the most accuracy-robust model, demonstrating that accuracy and safety robustness are independent properties. We additionally test two recovery methods, clinical calibration substitution and QLoRA fine-tuning, both producing the same trade-off: MedMCQA recovers while MedQA further degrades, indicating recovery strategies require task-specific validation rather than being assumed universally beneficial. These findings indicate INT8 is broadly safe for clinical deployment, while INT4 safety must be assessed per-model and per-task, and that safety alignment is determined primarily by instruction tuning rather than clinical domain adaptation.

  • 2 authors
·
Sep 1

LingSante MedGuard Technical Report

As medical AI is increasingly used for patient consultation and clinical decision support, identifying harmful, non-compliant, or ethically problematic responses is essential for responsible deployment. Assessing these risks requires checking clinical claims against relevant evidence, verifying calculations, and applying medical requirements under their intended conditions. We introduce LingSante MedGuard, a capability-enhanced guardrail that integrates supervision from a medical guardrail teacher model and six specialized medical capability experts into a unified model. The guardrail teacher supervises risk decisions and explanations across medical safety, compliance, and ethics, while the capability experts support medical rule understanding, numerical reasoning, multimodal hallucination detection, agentic safety verification, risk localization, and multimodal entity understanding. We consolidate these sources of supervision through offline supervised fine-tuning on teacher-generated demonstrations, followed by multi-teacher on-policy distillation using feedback on student-generated responses. We further introduce LingSante MedGuardBench, a benchmark comprising 11 risk-detection subsets spanning medical safety, compliance, and ethics. At 4B, 9B, and 27B scales, LingSante MedGuard achieves mean benchmark F1 scores of 82.3%, 82.4%, and 87.4%, respectively. The 4B model also achieves 73.9% mean accuracy across MedHallu and MedHALT-NOTA under retrieval-enabled evaluation. Additional evaluations of the verification components show improvements in evidence-supported consistency, source traceability, and rule-guided rationale quality across model scales. These results support the integration of specialized medical capabilities into a unified guardrail for medical risk assessment and evidence-based medical safety verification.

  • 1 authors
·
Nov 18